Sort
78,016 grants matching “breast cancer”
Leadership, Planning, and Evaluation
$501,296Patrick J Loehrer · Indiana University Indianapolis · P30 · FY2022 · CA
Leadership, Planning, and Evaluation
$501,296Kelvin P Lee · Indiana University Indianapolis · P30 · FY2023 · CA
Environmental exposure: Susceptibility alleles in a DNA damage response pathway
$501,254Peter J Stambrook · University Of Cincinnati · R01 · FY2012 · ES
Anticancer Agent Pharmacodynamics in Acute Leukemia
$501,228St. Jude Children'S Research Hospital · R01 · FY2004 · CA
Breast Cancer Treatment with Antibody Targeted T Cells
$501,226Lawrence G Lum · Wayne State University · R01 · FY2009 · CA
Integrated genomic analysis and multi-scale modeling of therapeutic resistance
$501,217Christina N Curtis · Stanford University · R01 · FY2015 · CA
Biomarkers for Staging and Treatment Response Monitoring of Bladder Cancer
$501,194Lubomir M Hadjiyski · University Of Michigan At Ann Arbor · U01 · FY2014 · CA
Impact of Social contagion on Physician use of unproven cancer interventions
$501,190Cary P Gross · Yale University · R01 · FY2014 · CA
Mechanisms of the spliceosome protein SF3B1 and inhibitors
$501,161Melissa S Jurica · University Of California Santa Cruz · R01 · FY2020 · GM
Breast PETX: Mammography Machine PET Scanner with Biopsy Guidance
$501,131Lawrence R Macdonald · University Of Washington · R01 · FY2016 · CA
Obestiy Reduction Black Intervention Trial (ORBIT)
$501,110Marian L Fitzgibbon · University Of Illinois At Chicago · R01 · FY2007 · CA
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles
$501,104Rulla M Tamimi · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Mechanical Regulation of Tumor Angiogenesis
$501,103Cynthia A Reinhart-King · Vanderbilt University · R01 · FY2018 · HL
Role of Metalloproteinases in Mammary Gland Remodeling
$501,095Zena Werb · University Of California, San Francisco · R01 · FY2006 · CA
Placental Responses to Environmental Chemicals
$501,053Lauren M Aleksunes · Rutgers, The State Univ Of N.J. · R01 · FY2021 · ES
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$501,022Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Targeting Estrogen Related Receptor alpha in triple negative breast cancer
$501,000Anya Alayev · Yeshiva University · R15 · FY2017 · CA
Blood-to-CNS Drug Uptake in Pain
$500,970Thomas Paul Davis · University Of Arizona · R01 · FY2011 · DA
IN VIVO MEASUREMENT OF DRUG EFFICACY IN BREAST CANCER
$500,968The General Hospital Corporation · · FY2014 · Department of the Army
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$500,945Xiang Zhang · Baylor College Of Medicine · R01 · FY2020 · CA
Dynamic Phase Imaging Interference 4D Microscope System
$500,934James Elstin Millerd · 4 D Technology Corporation · R44 · FY2011 · RR
Immune Enhancement and Therapy of Cancer
$500,932Douglas Hanahan · University Of California, San Francisco · U01 · FY2008 · CA
Intervention Trials in Persons at Increased Genetic Risk of Cancer
$500,914Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study
$500,886Cornelia M Ulrich · University Of Utah · R01 · FY2017 · CA
EXPLORING ANTITUMOR IMMUNE RESPONSE IN A NOVEL MLL3-MUTANT BREAST CANCER MODEL
$500,871Albert Einstein College Of Medicine, Inc. · · FY2017 · Department of the Army